| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
7 analysts have shared their evaluations of AMETEK (NYSE:AME) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 3 | 3 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 2 | 0 | 0 |
| 2M Ago | 1 | 3 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $204.71, a high estimate of $225.00, and a low estimate of $180.00. This current average has increased by 5.44% from the previous average price target of $194.14.
The standing of AMETEK among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Joe Giordano | TD Cowen | Raises | Hold | $180.00 | $158.00 |
| Christopher Snyder | Morgan Stanley | Raises | Equal-Weight | $198.00 | $185.00 |
| Richard Eastman | Baird | Raises | Neutral | $198.00 | $190.00 |
| Matt Summerville | DA Davidson | Raises | Buy | $215.00 | $210.00 |
| Brett Linzey | Mizuho | Raises | Outperform | $225.00 | $212.00 |
| Deane Dray | RBC Capital | Raises | Outperform | $212.00 | $209.00 |
| Steve Barger | Keybanc | Raises | Overweight | $205.00 | $195.00 |
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of AMETEK's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on AMETEK analyst ratings.
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: AMETEK displayed positive results in 3M. As of 30 June, 2025, the company achieved a solid revenue growth rate of approximately 2.49%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: AMETEK's net margin excels beyond industry benchmarks, reaching 20.16%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): AMETEK's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.52%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.38%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.19, AMETEK adopts a prudent financial strategy, indicating a balanced approach to debt management.
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: AME
